Spotlight
Video

TOX and the Tumor Microenvironment in Immunotherapy

Loading........
Description: James L. Gulley, MD, PhD of National Cancer Institute at the National Institutes of Health discusses promising approaches for looking at tumor microenvironment. He mentions a study that showed patients who received standard of care therapy plus immunotherapy had a better response rate than those who only received standard of care. This was recorded at the ASCO-SITC Clinical Immuno-Oncology Symposium in Orlando, Florida.
Shared By : ASCO-SITC2017
Posted on : 03/06/17
Added : 4 months ago
Category : Immunotherapy



Recommended

Nothing found.

More From ASCO-SITC2017

Nothing found.